Press release
Plant Phenotyping Market Projected to Reach $268.1 Million by 2023 | Key Players are LemnaTec , Delta-T Devices, CropDesign - BASF SE, Qubit Systems, KeyGene, Phenomix
The report "Plant Phenotyping Market by Product (Equipment (Site, Platform/Carrier, Application, Analysis System, Automation Level), Sensor (Image Sensors, NDVI Sensors, Temperature Sensors), and Software), Service, and Region - Global Forecast to 2023" The plant phenotyping market is estimated to be USD 158.2 million in 2018 and is projected to reach USD 268.1 million by 2023, at a CAGR of 11.14%. The market growth is driven by factors such as the growing demand for sustainable crop production using improved crop varieties and significant advancements in imaging sensors.Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=236591018
Among platform/carrier types, the application of drones for plant phenotyping is projected to be the fastest-growing during the forecast period.
Different types of plant phenotyping equipment include conveyor-based/modular systems, bench-based systems, portable/handheld systems, and drones. Conveyor-based systems are mostly preferred by plant breeders as there is a high demand for high-throughput phenotyping systems. The use of drones is projected to grow in the future as they have high demand in countries with limited manpower and higher ease in the procurement of data.
Among different phenotyping products, the software segment is projected to be the fastest-growing during the forecast period.
Flexible and extendable computational tools are required to address the diversity of plant phenotyping problems. Thus, the demand for software tools is projected to grow at a higher CAGR during the forecast period as they help to measure and provide reliable data about plant traits in a non-destructive manner through image analysis, data acquisition, and system controls.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=236591018
Europe is projected to dominate the plant phenotyping market through 2023.
The European region is estimated to account for the largest share in 2018 due to the strong presence of players such as LemnaTec (Germany), CropDesign - BASF SE (Germany), Heinz Walz (Germany), KeyGene (Netherlands), and Rothamsted Research (UK), which provide quality services to meet the research requirements of plant breeders. Moreover, increasing collaborations among companies and research institutions in the form of plant phenotyping initiatives, programs, networks, and consortiums have helped the region to remain competitive in the plant phenotyping market.
This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of key companies such as LemnaTec (Germany), Delta-T Devices (UK), CropDesign - BASF SE (Germany), Heinz Walz (Germany), Phenospex (Netherlands), WPS (Netherlands), Photon Systems Instruments (Czech Republic), Qubit Systems (Canada), KeyGene (Netherlands), Rothamsted Research (UK), The Vienna Biocenter Core Facilities (Austria), and Phenomix (France).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Plant Phenotyping Market Projected to Reach $268.1 Million by 2023 | Key Players are LemnaTec , Delta-T Devices, CropDesign - BASF SE, Qubit Systems, KeyGene, Phenomix here
News-ID: 1620610 • Views: …
More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…

Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for…
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow…
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…